Alyson Fox, our Director of Grants, explains why we’re changing our policy on transferring grants to ensure research can thrive in the UK, EU and beyond.
Director of Innovation Stephen Caddick explains how his team has built its global portfolio to around £1 billion, touching the lives of more than 1.8 million people.
Jeremy Farrar, Wellcome's Director, and Mike Ferguson, Deputy Chair of our Board of Governors, have both been knighted in the New Year's Honours 2019
During 2018 we've featured stories about trailblazing research by people we support. Here are some highlights.
At $60 billion a year, epidemics cost far more than putting in place the systems to prepare for them.
Our investments portfolio grew to almost £25.9 billion by 30 September 2018, strengthening our ambition to spend more than £5 billion over five years on charitable activities.
If we put research at the heart of epidemic response, it’s a double win – helping fight outbreaks that are underway and protecting us in the future.
We are extending our partnership with the Academy of Medical Sciences to £8.3 million to support early career researchers moving into an independent role. Alongside this, we’re going to close our Seed Awards in Science in March 2019.
The case for good public engagement in low- and middle-income countries is strong. But why, and what is Wellcome doing to ensure that our public engagement work makes a difference outside the UK?
A doctor and scientist of great compassion and intellect, Sir David Weatherall died on 8 December 2018. He was a member of Wellcome’s Board throughout the 1990s, helping to shape our support for science, particularly research in tropical medicine and genetics.
Researchers are helping to uncover ethical and practical challenges that are critical to the people caught in the middle of an epidemic.